Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial

Massimiliano Ruscica, Chiara Pavanello, Sara Gandini, Monica Gomaraschi, Cecilia Vitali, Chiara Macchi, Beatrice Morlotti, Gilda Aiello, Raffaella Bosisio, Laura Calabresi, Anna Arnoldi, Cesare R. Sirtori, Paolo Magni

Research output: Contribution to journalArticle

  • 1 Citations

Abstract

Background: Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. Methods: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. Results: Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (−1.5 %) and BMI (−1.5 %), as well as for atherogenic lipid markers, namely TC (−4.85 %), LDL-C (−5.25 %), non-HDL-C (−7.14 %) and apoB (−14.8 %). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 %) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 % of total variance, showing a statistically significant difference between treatment arms (p = 0.002). Conclusions: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.

LanguageEnglish
Pages1-13
Number of pages13
JournalEuropean Journal of Nutrition
DOIs
StateAccepted/In press - Oct 18 2016

Fingerprint

Metabolic Syndrome X
Randomized Controlled Trials
Soy Foods
Lipids
Soybean Proteins
Body Weight Changes
Intra-Abdominal Fat
Apolipoproteins B
Primary Prevention
Cause of Death
Proteins
Cardiovascular Diseases
Biomarkers
Diet
Food

Keywords

  • Lipids
  • Metabolic syndrome and obesity
  • Soy protein

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Cite this

Ruscica, M., Pavanello, C., Gandini, S., Gomaraschi, M., Vitali, C., Macchi, C., ... Magni, P. (Accepted/In press). Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial. European Journal of Nutrition, 1-13. DOI: 10.1007/s00394-016-1333-7

Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial. / Ruscica, Massimiliano; Pavanello, Chiara; Gandini, Sara; Gomaraschi, Monica; Vitali, Cecilia; Macchi, Chiara; Morlotti, Beatrice; Aiello, Gilda; Bosisio, Raffaella; Calabresi, Laura; Arnoldi, Anna; Sirtori, Cesare R.; Magni, Paolo.

In: European Journal of Nutrition, 18.10.2016, p. 1-13.

Research output: Contribution to journalArticle

Ruscica, M, Pavanello, C, Gandini, S, Gomaraschi, M, Vitali, C, Macchi, C, Morlotti, B, Aiello, G, Bosisio, R, Calabresi, L, Arnoldi, A, Sirtori, CR & Magni, P 2016, 'Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial' European Journal of Nutrition, pp. 1-13. DOI: 10.1007/s00394-016-1333-7
Ruscica, Massimiliano ; Pavanello, Chiara ; Gandini, Sara ; Gomaraschi, Monica ; Vitali, Cecilia ; Macchi, Chiara ; Morlotti, Beatrice ; Aiello, Gilda ; Bosisio, Raffaella ; Calabresi, Laura ; Arnoldi, Anna ; Sirtori, Cesare R. ; Magni, Paolo. / Effect of soy on metabolic syndrome and cardiovascular risk factors : a randomized controlled trial. In: European Journal of Nutrition. 2016 ; pp. 1-13
@article{544fc8d2aea042659a18364e7d6d979d,
title = "Effect of soy on metabolic syndrome and cardiovascular risk factors: a randomized controlled trial",
abstract = "Background: Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. Methods: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. Results: Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (−1.5 {\%}) and BMI (−1.5 {\%}), as well as for atherogenic lipid markers, namely TC (−4.85 {\%}), LDL-C (−5.25 {\%}), non-HDL-C (−7.14 {\%}) and apoB (−14.8 {\%}). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 {\%}) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 {\%} of total variance, showing a statistically significant difference between treatment arms (p = 0.002). Conclusions: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.",
keywords = "Lipids, Metabolic syndrome and obesity, Soy protein",
author = "Massimiliano Ruscica and Chiara Pavanello and Sara Gandini and Monica Gomaraschi and Cecilia Vitali and Chiara Macchi and Beatrice Morlotti and Gilda Aiello and Raffaella Bosisio and Laura Calabresi and Anna Arnoldi and Sirtori, {Cesare R.} and Paolo Magni",
year = "2016",
month = "10",
day = "18",
doi = "10.1007/s00394-016-1333-7",
language = "English",
pages = "1--13",
journal = "European Journal of Nutrition",
issn = "1436-6207",
publisher = "D. Steinkopff-Verlag",

}

TY - JOUR

T1 - Effect of soy on metabolic syndrome and cardiovascular risk factors

T2 - European Journal of Nutrition

AU - Ruscica,Massimiliano

AU - Pavanello,Chiara

AU - Gandini,Sara

AU - Gomaraschi,Monica

AU - Vitali,Cecilia

AU - Macchi,Chiara

AU - Morlotti,Beatrice

AU - Aiello,Gilda

AU - Bosisio,Raffaella

AU - Calabresi,Laura

AU - Arnoldi,Anna

AU - Sirtori,Cesare R.

AU - Magni,Paolo

PY - 2016/10/18

Y1 - 2016/10/18

N2 - Background: Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. Methods: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. Results: Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (−1.5 %) and BMI (−1.5 %), as well as for atherogenic lipid markers, namely TC (−4.85 %), LDL-C (−5.25 %), non-HDL-C (−7.14 %) and apoB (−14.8 %). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 %) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 % of total variance, showing a statistically significant difference between treatment arms (p = 0.002). Conclusions: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.

AB - Background: Cardiovascular diseases are currently the commonest cause of death worldwide. Different strategies for their primary prevention have been planned, taking into account the main known risk factors, which include an atherogenic lipid profile and visceral fat excess. Methods: The study was designed as a randomized, parallel, single-center study with a nutritional intervention duration of 12 weeks. Whole soy foods corresponding to 30 g/day soy protein were given in substitution of animal foods containing the same protein amount. Results: Soy nutritional intervention resulted in a reduction in the number of MetS features in 13/26 subjects. Moreover, in the soy group we observed a significant improvement of median percentage changes for body weight (−1.5 %) and BMI (−1.5 %), as well as for atherogenic lipid markers, namely TC (−4.85 %), LDL-C (−5.25 %), non-HDL-C (−7.14 %) and apoB (−14.8 %). Since the majority of the studied variables were strongly correlated, three factors were identified which explained the majority (52 %) of the total variance in the whole data set. Among them, factor 1, which loaded lipid and adipose variables, explained the 22 % of total variance, showing a statistically significant difference between treatment arms (p = 0.002). Conclusions: The inclusion of whole soy foods (corresponding to 30 g/day protein) in a lipid-lowering diet significantly improved a relevant set of biomarkers associated with cardiovascular risk.

KW - Lipids

KW - Metabolic syndrome and obesity

KW - Soy protein

UR - http://www.scopus.com/inward/record.url?scp=84991681874&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84991681874&partnerID=8YFLogxK

U2 - 10.1007/s00394-016-1333-7

DO - 10.1007/s00394-016-1333-7

M3 - Article

SP - 1

EP - 13

JO - European Journal of Nutrition

JF - European Journal of Nutrition

SN - 1436-6207

ER -